NASDAQ:NURO

Delisted

Neurometrix Stock News

Healthcare > Medical - Devices

Buy NURO

*Your capital is at risk

$4.58

+0 (+0%)

At Close: Jul 30, 2025

NeuroMetrix Reports Updates To Quell 2.: Will Shift Exclusively To Direct-To-Consumer Model Via QuellRelief.com

12:00am, Tuesday, 15'th Oct 2019

The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO

11:31am, Thursday, 10'th Oct 2019

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed Oct.

Volvo XC40 using Android Automotive on EV version - 9to5Google

08:04pm, Wednesday, 09'th Oct 2019

The upcoming all-electric Volvo XC40 is going to be using Google's Android Automotive platform for its infotainment system.

Stocks That Hit 52-Week Lows On Wednesday

12:00am, Wednesday, 09'th Oct 2019

The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo

12:00am, Thursday, 03'rd Oct 2019

Stocks That Hit 52-Week Lows On Monday

12:00am, Monday, 30'th Sep 2019

22 Healthcare Stocks Moving In Monday's Pre-Market Session

12:00am, Monday, 16'th Sep 2019

The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO

12:00am, Tuesday, 27'th Aug 2019

Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo ...

12:00am, Tuesday, 20'th Aug 2019

Stocks That Hit 52-Week Lows On Friday

12:00am, Friday, 16'th Aug 2019

The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings

12:00am, Thursday, 15'th Aug 2019

The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

12:00am, Thursday, 01'st Aug 2019

NeuroMetrix Q2 Sales $2.35M Miss $3.28M Estimate

12:00am, Thursday, 18'th Jul 2019

NeuroMetrix, Inc. Announces Date for Second Quarter —…–9 Financial Results Conference Call

12:00am, Thursday, 11'th Jul 2019

The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO

12:00am, Friday, 28'th Jun 2019

Neurometrix Stock News

NeuroMetrix Reports Updates To Quell 2.: Will Shift Exclusively To Direct-To-Consumer Model Via QuellRelief.com

The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO

Volvo XC40 using Android Automotive on EV version - 9to5Google

Stocks That Hit 52-Week Lows On Wednesday

The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo

Stocks That Hit 52-Week Lows On Monday

22 Healthcare Stocks Moving In Monday's Pre-Market Session

The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO

Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo ...

Stocks That Hit 52-Week Lows On Friday

The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings

The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

NeuroMetrix Q2 Sales $2.35M Miss $3.28M Estimate

NeuroMetrix, Inc. Announces Date for Second Quarter —…–9 Financial Results Conference Call

The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO

Top Fintech Company